Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

40 Results
authFullName_s : Javed Butler

Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

Piotr Ponikowski , Bridget-Anne Kirwan , Stefan Anker , Theresa Mcdonagh , Maria Dorobantu , et al.
The Lancet, 2020, 396 (10266), pp.1895-1904. ⟨10.1016/S0140-6736(20)32339-4⟩
Journal articles inserm-03935081v1
Image document

Abnormalities of Potassium in Heart Failure JACC State-of-the-Art Review

João Pedro Ferreira , Javed Butler , Patrick Rossignol , Bertram Pitt , Stefan D. Anker , et al.
Journal of the American College of Cardiology, 2020, 75, pp.2836 - 2850. ⟨10.1016/j.jacc.2020.04.021⟩
Journal articles hal-03490821v1
Image document

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

Paul W Armstrong , Burkert Pieske , Kevin J Anstrom , Justin Ezekowitz , Adrian F Hernandez , et al.
New England Journal of Medicine, 2020, 382 (20), pp.1883 - 1893. ⟨10.1056/nejmoa1915928⟩
Journal articles inserm-03935267v1
Image document

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial

Wolfram Doehner , Stefan D Anker , Javed Butler , Faiez Zannad , Gerasimos Filippatos , et al.
European Heart Journal, 2022, 43 (36), pp.3435-3446. ⟨10.1093/eurheartj/ehac320⟩
Journal articles hal-03792414v1
Image document

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload

Milton Packer , Stefan D Anker , Javed Butler , Gerasimos Filippatos , João Pedro Ferreira , et al.
Journal of the American College of Cardiology, 2021, 77 (11), pp.1381-1392. ⟨10.1016/j.jacc.2021.01.033⟩
Journal articles hal-03185917v1
Image document

Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy

James L Januzzi , Javed Butler , Stefano del Prato , Justin A Ezekowitz , Nasrien E Ibrahim , et al.
American Heart Journal, 2023, 256, pp.25-36. ⟨10.1016/j.ahj.2022.11.003⟩
Journal articles hal-03884375v1
Image document

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial

Milton Packer , Faiez Zannad , Javed Butler , Gerasimos Filippatos , Joao Pedro Ferreira , et al.
European Journal of Heart Failure, 2021, ⟨10.1002/ejhf.2334⟩
Journal articles hal-03357918v1
Image document

Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure

João Pedro Ferreira , Faiez Zannad , Stuart J Pocock , Stefan D Anker , Javed Butler , et al.
Journal of the American College of Cardiology, 2021, 77 (11), pp.1397-1407. ⟨10.1016/j.jacc.2021.01.044⟩
Journal articles hal-03185873v1
Image document

The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study

Ewa A Jankowska , Bridget-Anne Kirwan , Mikhail Kosiborod , Javed Butler , Stefan D Anker , et al.
European Heart Journal, 2011, 42 (31), pp.3021 - 3022. ⟨10.1093/eurheartj/ehab365⟩
Journal articles inserm-03934856v1
Image document

Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA)

Justin A Ezekowitz , Yinggan Zheng , Alain Cohen-Solal , Vojtěch Melenovský , Jorge Escobedo , et al.
Circulation, 2023, 144 (18), pp.1489 - 1499. ⟨10.1161/circulationaha.121.056797⟩
Journal articles inserm-03934690v1
Image document

Effect of Empagliflozin on Worsening Heart Failure Events in Patients with Heart Failure and a Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Milton Packer , Javed Butler , Faiez Zannad , Gerasimos Filippatos , Joao Pedro Ferreira , et al.
Journal articles hal-03358043v1
Image document

Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial

Stefan D Anker , Javed Butler , Gerasimos Filippatos , Muhammad Shahzeb Khan , Nikolaus Marx , et al.
Circulation, 2020, 143 (4), pp.337-349. ⟨10.1161/CIRCULATIONAHA.120.051824⟩
Journal articles hal-03014260v1
Image document

Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Javed Butler , Gerasimos Filippatos , Tariq Jamal Siddiqi , Martina Brueckmann , Michael Böhm , et al.
Journal articles hal-03467783v1
Image document

Empagliflozin for Heart Failure With Preserved Left Ventricular Ejection Fraction With and Without Diabetes

Gerasimos Filippatos , Javed Butler , Dimitrios Farmakis , Faiez Zannad , Anne Pernille Ofstad , et al.
Circulation, 2022, 146 (9), pp.676-686. ⟨10.1161/CIRCULATIONAHA.122.059785⟩
Journal articles hal-03791576v1
Image document

How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines?

Martin R Cowie , Biykem Bozkurt , Javed Butler , Andrew Briggs , Maria Kubin , et al.
International Journal of Cardiology, 2022, 365, pp.61-68. ⟨10.1016/j.ijcard.2022.07.020⟩
Journal articles hal-03800780v1
Image document

Effect of Empagliflozin on Circulating Proteomics in Heart Failure: Mechanistic Insights from the EMPEROR Program

Faiez Zannad , João Pedro Ferreira , Javed Butler , Gerasimos Filippatos , James L Januzzi , et al.
European Heart Journal, 2022, 43 (48), pp.4991-5002. ⟨10.1093/eurheartj/ehac495⟩
Journal articles hal-03793111v1
Image document

Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial

Stefan D Anker , Javed Butler , Gerasimos Filippatos , Muhammad Shahzeb Khan , João Pedro Ferreira , et al.
European Journal of Heart Failure, 2020, 22 (12), pp.2383-2392. ⟨10.1002/ejhf.2064⟩
Journal articles hal-03758946v1
Image document

Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial

Javed Butler , Stefan D Anker , Gerasimos Filippatos , Muhammad Shahzeb Khan , João Pedro Ferreira , et al.
European Heart Journal, 2021, ⟨10.1093/eurheartj/ehaa1007⟩
Journal articles hal-03115141v1
Image document

Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure

João Pedro Ferreira , Faiez Zannad , Javed Butler , Gerasimos Filippatos , Stuart J Pocock , et al.
JAMA Cardiology, 2022, 7 (11), pp.1148-1159. ⟨10.1001/jamacardio.2022.2924⟩
Journal articles hal-03798543v1
Image document

Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR ‐Reduced trial

Milton Packer , James L Januzzi , Joao Pedro Ferreira , Stefan D Anker , Javed Butler , et al.
European Journal of Heart Failure, 2021, 23 (9), pp.1529-1538. ⟨10.1002/ejhf.2256⟩
Journal articles hal-03717440v1
Image document

Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Reduced

Faiez Zannad , João Pedro Ferreira , John Gregson , Bettina Johanna Kraus , Michaela Mattheus , et al.
European Journal of Heart Failure, 2022, 24 (10), pp.1829-1839. ⟨10.1002/ejhf.2578⟩
Journal articles hal-03813870v1
Image document

Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

Javed Butler , Gerasimos Filippatos , Jamal Siddiqi , João Pedro Ferreira , Martina Brueckmann , et al.
Circulation, 2022, 146 (14), pp.1046-1055. ⟨10.1161/CIRCULATIONAHA.122.059755⟩
Journal articles hal-03795027v1
Image document

Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence

Massimo Volpe , Johann Bauersachs , Antoni Bayés-Genís , Javed Butler , Alain Cohen-Solal , et al.
International Journal of Cardiology, 2020, 327, pp.138 - 145. ⟨10.1016/j.ijcard.2020.11.071⟩
Journal articles inserm-03935024v1
Image document

Dosing of losartan in men versus women with heart failure with reduced ejection fraction: the HEAAL trial

João Pedro Ferreira , Marvin A Konstam , John J.V. Mcmurray , Javed Butler , Nicolas Girerd , et al.
European Journal of Heart Failure, 2021, 23 (9), pp.1477-1484. ⟨10.1002/ejhf.2255⟩
Journal articles hal-03701735v1
Image document

Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure

Michael Böhm , Stefan D Anker , Javed Butler , Gerasimos Filippatos , João Pedro Ferreira , et al.
Journal of the American College of Cardiology, 2021, 78 (13), pp.1337-1348. ⟨10.1016/j.jacc.2021.07.049⟩
Journal articles hal-03380278v1
Image document

Aspirin use is associated with increased risk for incident heart failure: a patient‐level pooled analysis

Blerim Mujaj , Zhen‐yu Zhang , Wen‐Yi Yang , Lutgarde Thijs , Fang‐fei Wei , et al.
ESC Heart Failure, 2021, ⟨10.1002/ehf2.13688⟩
Journal articles hal-03467860v1
Image document

Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

Javed Butler , Milton Packer , Gerasimos Filippatos , Joao Pedro Ferreira , Cordula Zeller , et al.
European Heart Journal, 2021, pp.ehab798. ⟨10.1093/eurheartj/ehab798⟩
Journal articles hal-03478833v1
Image document

Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial

Burkert Pieske , Mahesh J Patel , Cynthia M Westerhout , Kevin J Anstrom , Javed Butler , et al.
European Journal of Heart Failure, 2019, 21 (12), pp.1596 - 1604. ⟨10.1002/ejhf.1664⟩
Journal articles inserm-03935803v1
Image document

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions

Stefan D Anker , Tariq Jamal Siddiqi , Gerasimos Filippatos , Faiez Zannad , João Pedro Ferreira , et al.
European Journal of Heart Failure, 2022, 24 (8), pp.1400-1405. ⟨10.1002/ejhf.2558⟩
Journal articles hal-03797421v1
Image document

Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age

Michael Böhm , Javed Butler , Gerasimos Filippatos , João Pedro Ferreira , Stuart J Pocock , et al.
Journal of the American College of Cardiology, 2022, 80 (1), pp.1-18. ⟨10.1016/j.jacc.2022.04.040⟩
Journal articles hal-03791473v1